Diabetes

December 28, 2017

Molecular therapy for TIIDM and Metabolic defects: A pharmaceutical mixture (PMEA) encompassing Pyridoxamin (PM) and Etacrynic acid (EA)  increases Sirtuin-4 expression, augments insulin secretion, reduces metabolic stress, improves glucose uptake, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 29/December/2017, 12.03 am

Introduction: What they say A study from the “Duke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, NC […]
December 27, 2017

Natural product therapy for body weight control, energy homeostasis and TIIDM:  A pharmaceutical mixture[PMEA] encompassing Pyridoxamine (PM) and Etacrynic acid (EA)  decreases CADM1 and its downstream target genes that promote glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM via up regulation of its target gene, 28/December/2017, 1.21 am

Introduction: What they say A study from the Max Delbrück Center for Molecular Medicine, Berlin, Germany shows that “Regulation of body weight and energy homeostasis by […]
December 26, 2017

Natural product therapy for body weight control, energy homeostasis and TIIDM:Lycopene, isolated from Gac, Guava and Tomatoes,  decreases CADM1 and its downstream target genes that promote glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM via up regulation of its target gene, 27/December/2017, 12.20 am

Introduction: What they say A study from the Max Delbrück Center for Molecular Medicine, Berlin, Germany shows that “Regulation of body weight and energy homeostasis by […]
December 26, 2017

Natural product-based therapy for TIIDM: A pharmaceutical mixture encompassing Carnosic acid, Lycopene, Ferulic acid, and Glycyrrhizic acid (CALFAG) augments the expression of FGF19 and FGF1,   attenuates hepatic glucose production, decreases hepatic acetyl CoA content, brings down the levels of plasma ACTH, and corticosterone, augments insulin sensitivity, promotes weight loss and alleviates TIIDM via up regulation of its target gene, 26/December/2017, 11.59 pm

Introduction: What they say A study from Diabetes and Obesity Center of Excellence, Department of Medicine, University of Washington, Seattle, Washington, USA shows that Central injection […]